Innovations in Healthcare (1st in 2nd Series – Forum #5)
5:30 Networking & Dinner
6:30 Keynote: Summer Knight
7:30 Panel Discussions
8:30 Optional Networking & Dessert
3711 Market Street
Philadelphia, PA 19104
Join your colleagues for this exciting 5th event of our Innovation Series (first of the 2nd series) at Philadelphia Science Center. Innovation is the lifeblood of growth and the sustenance of our economy! This ILF event will focus on Innovations in Healthcare. (“Philly’s Unique Innovation Brand”). Healthcare Innovations involve all the facets of the healthcare value chain, from Pharmaceuticals to Biotech to Providers and Consumers. Please join us for this relevant discussion with key game changers who have a stellar reputation using all the tools that are at the disposal of truly innovative minds. Our noted speaker and panelists will explore the various facets of this very timely issue. We have a renowned keynote speaker who has been innovating throughout her career as a Physician, Entrepreneur and Visionary to lead to a very successful career in Innovation Consulting and Medical Insurance leadership, followed by a moderated panel discussion of our speaker and three more pioneers in startup and organizational transformation, including big changes going on at our institutions of higher learning and social media. It is bound to be a stimulating session. Don’t Miss It!!
Summer Knight, MD, MBA, currently serves as National Medical Executive for Cigna, Inc.
Dr. Knight is an entrepreneur doctor turned businesswoman. She is a founder and leads Springboard Partners, a consulting group of CEOs and powerful entrepreneurs who facilitate the rapid growth of scalable businesses. Dr. Knight also leads the DSK brand focused on empowering people to live their GREATest lives. Summer Knight loves to have fun, inspire people to succeed, and facilitate transformation in individuals and organizations.
As the former Chief Medical Officer of the State of Florida, Dr. Summer Knight worked with the Agency for Health Care Administration, influencing Medicaid policy, health care facility regulations, and stakeholder interactions. Through this experience, Dr. Knight saw an opportunity to increase health care quality and stakeholder communication while abolishing fraud, so she started her first company called IntegriCor, which stood for “Integrity Corporation.” Within years, this technology became the leading platform for long-term care integrity in several state markets.
Called “Dr. Biz” by friends, Dr. Summer Knight has participated in creating scalable entrepreneurial businesses and supported high-growth organizations as a consultant and joining organizations in their C-suite as CEO or Chief Medical Officer in different markets. She has extensive experience in Strategic Planning and Transformation, Problem Solving, CEO and leadership coaching, Capital Acquisition, Business Development, Sales and Marketing, Health Care innovations, and Implementation.
In addition to her corporate duties, Dr. Knight is involved with several key professional organizations. She founded the State Government Physician Leadership Council and was appointed by the Governor to the Florida Cancer Control and Research Advisory Committee. She also has served on the boards of the Florida Dialogue on Cancer Access Committee; the Pharmacy and Therapeutics Committee at Capital Health Plan; and both the Quality Practice Management Committee and the Governmental Affairs Committee with the Florida Academy of Family Physicians. She values her many speaking opportunities, which include Medicaid Management Information System and Home and Community Based Services national meetings, the Council of State Government for Disease Management in Washington, DC, the Florida Medical Association, the Florida College of Emergency Physicians, and the Florida Medical Directors Association.
Dr. Knight is active in the community. She serves as a college Trustee. She is a member of a community Leadership organization, founder member of Oasis Center for Woman and Girls, served locally on the board of Big Brother Big Sister, and the Advisory Committee of Tallahassee Community College Florida Scholarship Achievement. She has served as Secretary and Sub-Committee Chair for the Gilchrist Elementary School Advisory Committee, and received the Outstanding School Volunteer Award from the school’s PTA during the 2008 school year. She has also volunteered with organizations such as Cornerstone Learning Center, Refuge House, and the Governor’s Mentoring Initiative.
Dr. Knight received her M.D. from the University of Illinois at Chicago and her MBA from Warrington College of Business at the University of Gainesville. She has gained valuable medical experience as a family physician, urgent care, Emergency Room physician, and a former firefighter/paramedic.
Steve Tang became President and CEO of the Science Center in February 2008 following an extensive nationwide search. He brings to the position a wealth of professional experience in academia, professional services, and private industry. Most notably, Dr. Tang is the first president in the Science Center’s history to have not only led a company through venture funding and an initial public offering, but to also serve as a senior executive with a large life sciences company as it acquired and integrated smaller start-ups.
A seasoned life science, energy technology, and management consulting executive, Steve previously served as Group Vice President and General Manager with Olympus America Inc., where he led U.S. operations for the company’s $1 billion global Life Science businesses. Before joining Olympus in 2005, he was president and CEO of Millennium Cell Inc. (NASDAQ: MCEL), an energy technology firm he led through its initial public offering in 2000.
Previously, he served as Vice President and Managing Director of the global pharmaceutical and healthcare practice of A.T. Kearney Inc., and was Vice President and Co-managing Director of the global chemical and environmental practice for Gemini Consulting Inc., now known as Cap Gemini. Prior to that, he was the Assistant Director and Senior Research Engineer at the Lehigh University Center for Molecular Bioscience and Biotechnology in Bethlehem, Pennsylvania.
Dr. Tang earned a doctorate in Chemical Engineering from Lehigh University, an M.B.A. from the Wharton School of Business at the University of Pennsylvania, and a B.S. in Chemistry from the College of William and Mary. A graduate of the public school system in Delaware, he has resided in the area for most of his life.
Malcolm Bohm is a recognized expert in Life Sciences. In the industry since 1993, Malcolm served in increasingly senior positions at major pharmaceutical companies including Astra, Pfizer, and Novartis. In 2005 Malcolm established a successful US affiliate for biotech firm, Aspreva Pharmaceuticals. In 2006 he created Trialytics, an industry leading software solution leveraging electronic healthcare data to redefine clinical R&D strategies eventually selling the company to SDI Health Inc. Malcolm was educated in Great Britain and achieved a Bachelor of Science degree in Physiology and a Master of Medical Sciences degree in Renal Physiology and Pharmacology along with advanced training in analytical data modeling.
Malcolm is a recognized expert in Life Sciences. In the industry since 1993, Malcolm served in increasingly senior positions at major pharmaceutical companies including Astra, Pfizer, and Novartis. In 2005 Malcolm established a successful US affiliate for biotech firm, Aspreva Pharmaceuticals. In 2006 he created Trialytics, an industry leading software solution leveraging electronic healthcare data to redefine clinical R&D strategies eventually selling the company to SDI Health Inc. Malcolm was educated in Great Britain and achieved a Bachelor of Science degree in Physiology and a Master of Medical Sciences degree in Renal Physiology and Pharmacology along with advanced training in analytical data modeling.
Anthony P. Green, Ph.D. is Vice President of Technology Commercialization: Life Sciences for Ben Franklin. Dr. Green has over thirty years of experience in the biotechnology industry, with a specialization in the research, development and commercialization of cutting-edge technologies. The Technology Commercialization Group creates pathways to commercialization for companies and researchers by building consortia with universities, government and private partners.
Dr. Green leads Ben Franklin’s region-wide technology partnerships and major initiatives, including the Nanotechnology Institute™, the Energy Commercialization Institute, the Mid-Atlantic Nanotechnology Alliance (MANA®), various life sciences related initiatives, and efforts around the development of new commercialization models.
Dr. Green earned a Sc.B in Immunology with Honors from Brown University, and a Ph.D. in Microbiology and Immunology at Temple University School of Medicine.